Competent Cells Market is Expected to Grow at USD 2,318.6 Million By 2023


Growing demand for recombinant proteins and molecular cloned products, advancement in molecular cloning research with emergence of new technologies, and various government initiatives and availability of funding for life science research are the key drivers propelling the industry growth during the forecast period. Moreover, emerging economies such as Latin America, Asia Pacific, & Africa provides significant opportunity in this market. However, factors such as high cost of cloning based research and shortage of skilled professionals for handling of competent cells hinder the growth of this market in many parts of the globe.
Cloning is a process used to produce genetically identical copies of a biological entity. These copies are referred to as clones. Since last decade, researchers are cloning a wide range of biological material namely genes, cells, tissues, or entire organisms. For this, the natural competence of a cell or bacteria or genome is highly important i.e. it must possess the ability to take up the external DNA naturally.
However, with some organism’s inability to take up the external DNA and limitations associated with natural competence have led to the development of artificially competent cells. These artificial competent cells increase the reliability and efficiency of transformation based experiments. Further, researchers used this artificially mediated transformation for repairing genes and thereby contribute to genome maintenance or acquisition of genetic diversity. 


Global competent cells market is expected to reach USD 2,318.6 million by 2023, at a CAGR of 10.0% during the forecast period of 2018 to 2023.
Succeeding an extensive secondary and primary research on competent cells and in-depth analysis of the market scenario, the report carries out an impact analysis of the key industry drivers, restraint, opportunities, and challenges in the market dynamics segment.
pharmaceutical and biotechnology industry commanded the largest share in the global competent cells market in 2017, mainly due to higher adoption of competent cells by pharmaceutical & biotechnology companies with growing demand for molecular cloning with advancements in the cloning technologies, and rising investments in research & development to fulfill the demand for protein based therapeutics.


About Meticulous Research®
Meticulous Research® is founded in 2010 and incorporated as Meticulous Market Research Pvt. Ltd. in 2013 as a private limited company under the Companies Act, 1956. Since its incorporation, the company has become the leading provider of premium market intelligence in North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa.

Contact Us:
Viren Shrivastava

AVP- Global Sales and Marketing
Meticulous Research®
Tel: +1-646-781-8004



Comments

Popular posts from this blog

Organic fertilizers market : Top-10 Companies

Recreational Boats Market By Type (Inboard And Sterndrive Boats, Outboard, Sailboats), Material (Fiberglass, Wood, Inflatable), Application (Fishing, Travel & Tourism, Defense) – Global Opportunity Analysis And Industry Forecast (2017-2023)

Spirulina: The Greatest Super Food On Earth?